02359.HK
WuXi AppTec Co., Ltd.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 191.10
−0.57%Sep 3, 2026, 09:07 UTC
JPMorgan reduced its long position in WuXi AppTec H-shares from 10.54% to 10.27% on August 28, 2026, as disclosed by the Hong Kong Stock Exchange.
Source:Sep 3, 2026, 08:49 UTC
WuXi AppTec converted its zero-coupon convertible bonds due 2027 into 7,166,606 new H shares on September 3, 2026.
Sep 2, 2026, 08:49 UTC
WuXi AppTec issued 13,631,632 H shares on August 28, 2026 due to conversion of its zero-coupon convertible bonds due 2027, increasing its H-share count.
Source:Sep 1, 2026, 09:10 UTC
Goldman Sachs reduced its long position in WuXi AppTec H-shares from 5.15% to 4.9% on August 28, 2026, as disclosed by the Hong Kong Stock Exchange.
Source:Aug 28, 2026, 09:23 UTC
JPMorgan Chase reduced its long position in WuXi AppTec H shares from 12.09% to 10.90% on August 24.
Source:Aug 27, 2026, 10:10 UTC
WuXi AppTec announced an interim A-share dividend of 5.10 yuan per 10 shares for the first half of 2026, totaling 1.256 billion yuan, with record date September 3, 2026 and payment date September 4, 2026.
Source:Aug 26, 2026, 10:13 UTC
Hong Kong Exchanges and Clearing disclosed that JPMorgan Chase increased its stake in WuXi AppTec's H shares from 10.82% to 12.09% on August 21.
Source:Aug 24, 2026, 14:09 UTC
WuXi AppTec's DNA Encoded Library (DEL) platform suffered a cybersecurity incident; the company activated emergency response, hired external experts, and reported normal operations with no evidence of data misuse.
Aug 17, 2026, 09:06 UTC
BlackRock increased its long position in WuXi AppTec H-shares to 6.0% on August 12, 2026, from 5.94%, at an average price of HKD 198.87 per share.
Source:Aug 9, 2026, 09:54 UTC
WuXi AppTec obtained approval from the U.S. District Court for the District of Columbia on August 7, 2026 for its preliminary injunction motion, prohibiting the U.S. Department of Defense from enforcing the 1260H designation, to avoid immediate adverse effects during judicial review.
Aug 4, 2026, 08:45 UTC
WuXi AppTec announced that as of July 31, 2026, the total issued amount of its USD-denominated zero-coupon convertible bonds due 2027 was RMB 6.780 billion, with no change during the month.
Source:Aug 4, 2026, 04:15 UTC
Blackstone is considering a fresh funding injection into Nvidia-backed AI coding firm Factory, likely valuing the company at over $3.5 billion.
Source:Aug 3, 2026, 11:54 UTC
WuXi AppTec announced on August 3, 2026 that it would start construction of the Changzhou new base ahead of schedule to accelerate global capacity expansion and meet surging customer demand.
Source:Aug 3, 2026, 10:00 UTC
WuXi AppTec announced a 2026 A-share employee stock ownership plan, granting up to 9.7012 million A-shares to no more than 4,000 management and core technical staff at a purchase price of 103.08 yuan per share, funded by a long-term incentive fund of up to 1 billion yuan.
Source:Aug 3, 2026, 09:47 UTC
WuXi AppTec released its 2026 interim report on August 3, reporting revenue of 28.897 billion yuan, up 38.93% year-on-year, and net profit attributable to shareholders of 11.08 billion yuan, up 29.43% year-on-year.
Jul 4, 2026, 11:52 UTC
Hong Kong-listed companies, led by Tencent Holdings, AIA Group, and Xiaomi Corporation, have conducted share buybacks totaling over 900 billion Hong Kong dollars year-to-date, with June 2026 reaching a monthly record of over 300 billion Hong Kong dollars.
Jul 3, 2026, 01:44 UTC
Nona Biosciences appointed Wang Peng as Chief Operating Officer, effective July 3.
Source:Jul 2, 2026, 21:45 UTC
Alibaba and WuXi AppTec filed lawsuits challenging their designation on the Pentagon's 1260H List.
Source:Jul 2, 2026, 21:45 UTC
The Pentagon published an updated 1260H List on June 8, 2025, adding Alibaba, BYD, WuXi AppTec, and Zhongji Innolight as Chinese military-linked companies.
Source: